Bell Bank decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,716 shares of the medical research company’s stock after selling 146 shares during the period. Bell Bank’s holdings in Charles River […]